Skip to main content

RAYONIER INC

For the period ended Sep 30, 2025. Filed Nov 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 7, 2025

RYN$21.55-1.6%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Note

  1. DEBT

Our debt consisted of the following at September 30, 2025:

September 30, 2025
Debt
Senior Notes due 2031 at a fixed interest rate of 2.75%$450,000
2015 Term Loan borrowings due 2028 at a variable interest rate of 5.94%200,000
2016 Incremental Term Loan borrowings due 2026 at a variable interest rate of 6.09%200,000
2021 Incremental Term Loan borrowings due 2029 at a variable interest rate of 6.26%200,000
Total principal debt1,050,000
Less: Current maturities of long-term debt, net of deferred financing costs of $31(199,969)
Less: Unamortized discounts(2,167)
Less: Deferred financing costs(2,745)
Total long-term debt, net$845,119

The following table contains information on the outstanding variable rate debt as of September 30, 2025:

DebtPeriodic Interest RateEffective Fixed Interest Rate (a)
2015 Term LoanDaily Simple SOFR + 1.60%2.11%
2016 Incremental Term LoanDaily Simple SOFR + 1.75%2.39%
2021 Incremental Term LoanDaily Simple SOFR + 1.92%1.72%

(a) Effective interest rate is after consideration of interest rate swaps and estimated patronage.

Principal payments due during the next five years and thereafter are as follows:

Total
2025—
2026$200,000
2027—
2028200,000
2029200,000
Thereafter450,000
Total debt$1,050,000

2025 DEBT ACTIVITY

REVOLVING CREDIT FACILITY

In August 2025, we amended and restated our credit agreement, primarily to extend the maturity date of the Revolving Credit Facility. The maturity of the $300 million Revolving Credit Facility was extended from June 2026 to August 2030.

In connection with the amendment, we concurrently modified the following terms:

The commitment under the Revolving Credit Facility was reduced from $300 million to $200 million.

The 0.1% credit spread adjustment previously added to the Revolving Credit Facility during the 2022 transition from LIBOR to SOFR was eliminated.

The 0.1% credit spread adjustment on each of our three Term Loans was merged into the respective Term loan’s base rate. This modification resulted in no change to the all-in fixed rate for each Term loan.

In connection with the amendments, we recorded deferred financing costs in the amount of $0.8 million, which will be amortized to interest expense over the term of the extended credit agreement.

During the nine months ended September 30, 2025, we madeno borrowings or repayments on our Revolving Credit Facility. At September 30, 2025, we had available borrowings of $192.4 million under the Revolving Credit Facility, net of $7.6 million securing outstanding letters of credit.

DEBT COVENANTS

In connection with our 2015 Term Loan Agreement, 2016 Incremental Term Loan Agreement, 2021 Incremental Term Loan Agreement and Revolving Credit Facility, customary covenants must be met, the most significant of which include interest coverage and leverage ratios.

The covenants listed below, which are the most significant financial covenants in effect as of September 30, 2025, are calculated on a trailing 12-month basis:

Covenant RequirementActual RatioFavorable
Covenant EBITDA to consolidated interest expense should not be less than2.5 to 110.9 to 18.4
Covenant debt to covenant net worth plus covenant debt shall not exceed65%33%32%

In addition to the financial covenants listed above, the Senior Notes due 2031, 2015 Term Loan Agreement, 2016 Incremental Term Loan Agreement, 2021 Incremental Term Loan Agreement, and Revolving Credit Facility include customary covenants that limit the incurrence of debt and the disposition of assets, among others. Prior to the sale of our New Zealand subsidiary, we obtained a consent agreement from the lenders party to the aforementioned term loan and incremental term loan agreements, as well as our revolving credit facility, which provided a one-time modification to waive certain disposition-related covenants contained therein. Therefore, the consideration received from the New Zealand disposition did not count towards our defined disposition limits. At September 30, 2025, we were in compliance with all applicable covenants.

  1. DERIVATIVE FINANCIAL INSTRUMENTS AND HEDGING ACTIVITIES

Our financial results are subject to market risk from potential changes in interest rates. To manage this exposure, we utilize derivative financial instruments.

We account for derivative financial instruments under ASC Topic 815, Derivatives and Hedging, (“ASC 815”), and record them at fair value as assets or liabilities in the Consolidated Balance Sheets. The accounting for changes in their fair value depends on their intended use. Gains and losses on derivatives that are designated and qualify as cash flow hedges are initially recorded in accumulated other comprehensive income (“AOCI”) and subsequently reclassified into earnings when the hedged transaction occurs. Changes in the fair value of derivatives not designated as hedges, or those that cease to be effective, are recognized immediately in earnings.

INTEREST RATE PRODUCTS

We are exposed to cash flow interest rate risk on our variable-rate debt. To hedge this exposure, we use variable-to-fixed interest rate swaps. For these swaps, the gains or losses from changes in their fair value are reported in AOCI and are reclassified to interest expense in the period the hedged interest payments affect earnings.

In the event that a cash flow hedge is de-designated or terminated while the hedged item remains, the unrealized gain or loss on the hedge at the time of de-designation remains in AOCI and is amortized to interest expense on a straight-line basis over the remaining life of the hedged item. Conversely, if the hedged item becomes ineffective, the related gain or loss is immediately reclassified from AOCI to earnings.

INTEREST RATE SWAPS

The following table contains information on the outstanding interest rate swaps as of September 30, 2025:

Outstanding Interest Rate Swaps (a)
Date Entered IntoTermNotional AmountRelated Debt FacilityFixed Rate of SwapBank Margin on DebtTotal Effective Interest Rate (b)
April 201610 years$100,0002016 Incremental Term Loan1.50%1.75%3.25%
April 201610 years100,0002016 Incremental Term Loan1.51%1.75%3.26%
February 20227 years200,0002021 Incremental Term Loan0.67%1.92%2.59%
August 20244 years100,0002015 Term Loan0.78%1.60%2.38%
August 20244 years50,0002015 Term Loan0.64%1.60%2.24%
August 20244 years50,0002015 Term Loan3.29%1.60%4.89%

(a)All interest rate swaps are designated as cash flow hedges and qualify for hedge accounting.

(b)Rate is before estimated patronage payments.

The following table demonstrates the impact, gross of tax, of our derivatives on the Consolidated Statements of Income and Comprehensive Income (Loss) for the three and nine months ended September 30, 2025 and 2024:

Three Months Ended September 30, · Nine Months EndedSeptember 30,
Income Statement Location2025202420252024
Derivatives designated as cash flow hedges:
Interest rate productsOther comprehensive income (loss), relating to continuing operations$865($14,949)($4,821)$5,273
Interest expense, net(4,614)(6,822)(13,654)(21,379)

During the next 12 months, the amount of the AOCI balance, net of tax, expected to be reclassified into earnings is a gain of approximately $11.9 million. The following table provides details of these expected reclassifications:

Amount expected to be reclassified into earnings in next 12 months
Derivatives designated as cash flow hedges:
Interest rate products (a)$11,908
Total estimated net gain on derivatives contracts$11,908

(a) These reclassified amounts are expected to perfectly offset variable interest rate payments to debt holders, resulting in no net impact on our earnings or cash flows.

The following table contains the notional amounts of the derivative financial instruments recorded in the Consolidated Balance Sheets at September 30, 2025 and December 31, 2024:

Notional Amount
September 30, 2025December 31, 2024
Derivatives designated as cash flow hedges:
Interest rate swaps$600,000$600,000

The following table contains the fair values of the derivative financial instruments recorded in the Consolidated Balance Sheets at September 30, 2025 and December 31, 2024:

Location on Balance Sheet · Fair Value Assets / (Liabilities) (a)
September 30, 2025 · December 31, 2024
Derivatives designated as cash flow hedges:
Interest rate swapsOther current assets$2,634—
Other assets27,54849,353
Total derivative assets$30,182$49,353

(a) See Note 9 — Fair Value Measurements for further information on the fair value of our derivatives including their classification within the fair value hierarchy.

OFFSETTING DERIVATIVES

We present derivative financial instruments at their gross fair values in the Consolidated Balance Sheets. These instruments are not subject to master netting arrangements that would permit the right of offset.

  1. FAIR VALUE MEASUREMENTS

FAIR VALUE OF FINANCIAL INSTRUMENTS

A three-level hierarchy that prioritizes the inputs used to measure fair value was established in the Accounting Standards Codification as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than quoted prices included in Level 1.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The following table presents the carrying amount and estimated fair values of our financial instruments as of September 30, 2025 and December 31, 2024, using market information valuation methodologies we believe are appropriate under GAAP:

September 30, 2025 · December 31, 2024
Asset (Liability) (a) · CarryingAmount · Fair Value · CarryingAmount · Fair Value
Level 1 · Level 2 · Level 1 · Level 2
Cash and cash equivalents$919,582$919,582—$303,065$303,065—
Restricted cash, current (b)———19,36619,366—
Restricted cash, non-current (b)677677—676676—
Current maturities of long-term debt (c)(199,969)—(200,000)———
Long-term debt (c)(845,119)—(804,100)(1,044,410)—(980,970)
Interest rate swaps (d)30,182—30,18249,353—49,353
Noncontrolling interests in the Operating Partnership (e)46,242—46,24251,843—51,843

(a)We did not have Level 3 assets or liabilities at September 30, 2025 or December 31, 2024.

(b)Restricted cash includes proceeds from like-kind exchange sales held by a third-party intermediary and cash held in escrow. See Note 18 — Restricted Cash for additional information.

(c)The carrying amount of long-term debt is presented net of deferred financing costs and unamortized discounts on non-revolving debt. See Note 7 — Debt for additional information.

(d)See Note 8 — Derivative Financial Instruments and Hedging Activities for information regarding the Consolidated Balance Sheets classification of our derivative financial instruments.

(e)Noncontrolling interests in the Operating Partnership, representing ownership of Rayonier, L.P. units by parties other than the Company, are classified as temporary equity and are neither assets nor liabilities on the Company’s Consolidated Balance Sheets. See Note 5 — Noncontrolling Interests for additional information.

We use the following methods and assumptions in estimating the fair value of our financial instruments:

Cash and cash equivalents and Restricted cash — The carrying amount is equal to fair market value.

Debt — The fair value of fixed-rate debt is determined using quoted market prices for debt with comparable terms and maturities. For variable-rate debt, the carrying value approximates fair value as the interest rate adjusts with market changes.

Interest rate swap agreements — The fair value of interest rate contracts is determined by discounting the expected future cash flows for each instrument at prevailing interest rates.

Noncontrolling interests in the Operating Partnership — The fair value of noncontrolling interests in the Operating Partnership is determined by using the period-end closing price of Rayonier Inc. common shares.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.